Cambridge Innovation Capital (CIC) has launched a £100 million Opportunity Fund aimed at supporting deeptech and life sciences startups in the UK. The fund is backed by British Patient Capital and Aviva Investors and is designed to address the scale-up financing gap for high-growth companies. This initiative comes as part of efforts to retain innovative firms within the UK and stem the trend of later-stage funding flight. The launch was reported by various sources, highlighting the significance of this investment in the UK’s technology and healthcare sectors.